Article Details

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 ...

Retrieved on: 2021-03-02 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 .... View article details on hiswai:

Excerpt

... care including high dose steroids (>90%) and remdesivir (>65%); Cerecor has applied for FDA Breakthrough Therapy and Fast Track Designations, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up